Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common dysimmune neuropathy and commonly affects patients during active phase of life. 1 Clinical presentations of CIDP are ...

CNW/ - argenx SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada ...

The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...

Based on their findings, the authors concluded that the evaluation of the distribution of nerve enlargement offers significant diagnostic advantages. Nerve ultrasound is a “highly promising” tool for ...

I had already been on quite a journey by the time the words “sural nerve biopsy” were brought up. My team of neurologists was almost certain I had chronic inflammatory demyelinating polyneuropathy ...

VYVGART ® SC is first and only neonatal Fc receptor blocker approved to treat CIDP Authorization is based on global ADHERE study, the largest clinical trial in CIDP to date First novel, targeted ...

Chronic Inflammatory Demyelinating Polyneuropathy — or CIDP — is a rare but treatable nerve condition. It happens when the body’s immune system mistakenly attacks the protective covering (called ...

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare neurological disorder that can be tough to pin down. It causes muscle weakness, numbness, and balance problems that may resemble more ...

Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a potential first-in-class treatment Japanese Ministry of Health, Labour and Welfare decision adds to similar ...

WAYNE, Pennsylvania (WPVI) -- One step at a time, those who are diagnosed with rare neuropathic conditions such as GBS or CIDP prove it's possible to get back on their feet. A great place to see their ...